Latest Breaking News On - Displays preliminary efficacy - Page 1 : comparemela.com

Joyce F. Liu, MD, MPH, provides insights on WEE1 which has emerged as a potentially targetable pathway in high-grade serous ovarian cancer.

United statesDana farber cancer instituteSri lankaJoycef liuEnd results programZentalis pharmaceuticalsWomen healthHarvard medical schoolDivision of gynecologic oncologyAmerican society of clinical oncology annual meetingNational cancer institute surveillanceGynecologic oncologyDisplays preliminary efficacyClinical oncology annual meetingGynecologic oncology annual meetingCancer institute surveillance